meglumine has been researched along with Cancer of Pancreas in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 11 (52.38) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Djaker, N; Khan, M; Li, X; Liu, H; Marsich, E; Sacco, P; Spadavecchia, J | 1 |
| Kalantari, K; Swaminathan, S | 1 |
| Ambrosetti, MC; Capelli, P; Catania, M; D'Onofrio, M; De Robertis, R; Marchegiani, G; Salvia, R | 1 |
| Cassinotto, C; Chiche, L; Dilly, M; Feldis, M; Laurent, F; Marty, M | 1 |
| Bosetti, D; Castelli, F; Di Paola, V; Manfredi, R; Mucelli, RP; Negrelli, R; Ventriglia, A; Zantedeschi, L | 1 |
| Adsay, NV; Chen, Z; Erickson, SH; Gober, D; Kalb, B; Martin, DR; Sarmiento, JM; Tapper, EB | 1 |
| Cote, GA; Dhanabal, A; Nutakki, K; Sandrasegaran, K; Tahir, B; Tann, M | 1 |
| Byun, JH; Kang, BK; Kim, HJ; Kim, JH; Kim, SY; Lee, MG; Lee, SS | 1 |
| Boulay-Coletta, I; Duchatelle, V; Legrand, L; Molinié, V; Sibileau, E; Zins, M | 1 |
| Choi, BI; Choi, HK; Han, JK; Hong, SH; Lee, JM; Park, HS | 1 |
| Choi, BI; Han, JK; Kim, MA; Kim, SH; Lee, JM; Lee, JY; Yu, MH | 1 |
| Ba-Ssalamah, A; Goetzinger, P; Koelblinger, C; Plank, C; Puchner, S; Sahora, K; Scharitzer, M; Schima, W; Weber, M | 1 |
| Bali, MA; Closset, J; Delhaye, M; Demetter, P; Denolin, V; Matos, C; Metens, T | 1 |
| Liang, W | 1 |
| Agombar, A; Cooper, AJ; Johnson, CD | 1 |
| Gabata, T; Kadoya, M; Kayahara, M; Matsui, O; Miyayama, S; Nagakawa, T; Nonomura, A; Takashima, T; Yoshikawa, J | 1 |
| Cumming, MJ; Greenberg, HM; Kroeker, MA; Magro, CM; Semelka, RC; Shoenut, JP; Yaffe, CS | 1 |
| Hori, S; Miyata, M; Monden, M; Murakami, T; Nakamura, H; Osuga, K; Tomoda, K; Tsuda, K; Wakasa, K | 1 |
| Barr, B; Bestervelt, L; Dethloff, L | 1 |
| Bauters, W; Cuvelier, C; Kunnen, M; Mortelé, KJ; Oei, A; Ros, PR; Timmermans, F | 1 |
| Kroeker, MA; Kroeker, R; Micflikier, AB; Semelka, RC; Shoenut, JP; Yaffe, CS | 1 |
21 other study(ies) available for meglumine and Cancer of Pancreas
| Article | Year |
|---|---|
DOTAREM (DOTA)-Gold-Nanoparticles: Design, Spectroscopic Evaluation to Build Hybrid Contrast Agents to Applications in Nanomedecine.
Topics: Animals; Chitosan; Cholangiocarcinoma; Contrast Media; Gold; Heterocyclic Compounds, 1-Ring; Humans; Lactose; Meglumine; Metal Nanoparticles; Mice; Organometallic Compounds; Pancreatic Neoplasms; Polymers | 2022 |
Use of Gadolinium in Individuals with Reduced Kidney Function.
Topics: Aged; Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Male; Meglumine; Nephrectomy; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Pancreatic Neoplasms; Renal Dialysis; Risk Assessment | 2021 |
Solid Pseudopapillary Neoplasms of the Pancreas: Clinicopathologic and Radiologic Features According to Size.
Topics: Adolescent; Adult; Age Factors; Aged; Carcinoma, Papillary; Child; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Neoplasms; Retrospective Studies; Siloxanes; Tomography, X-Ray Computed; Tumor Burden | 2019 |
Pancreatic serous cystadenoma with signs of compression.
Topics: Constriction, Pathologic; Contrast Media; Cooperative Behavior; Cystadenoma, Serous; Humans; Interdisciplinary Communication; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Pancreatic Ducts; Pancreatic Neoplasms; Pancreaticoduodenectomy; Positron-Emission Tomography; Radionuclide Imaging; Somatostatin; Tomography, X-Ray Computed | 2013 |
Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Disease Progression; Female; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Neoplasms | 2013 |
Paraduodenal pancreatitis: clinical performance of MR imaging in distinguishing from carcinoma.
Topics: Adenocarcinoma; Aged; Carcinoma, Pancreatic Ductal; Contrast Media; Diagnosis, Differential; Duodenal Diseases; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2013 |
Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Humans; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Neoplasms; Pancreatitis; Retrospective Studies | 2013 |
Diffusion-weighted MRI: usefulness for differentiating intrapancreatic accessory spleen and small hypervascular neuroendocrine tumor of the pancreas.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Enhancement; Male; Meglumine; Middle Aged; Neuroendocrine Tumors; Observer Variation; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Spleen; Splenic Diseases; Young Adult | 2014 |
Pancreatic adenocarcinoma: MRI conspicuity and pathologic correlations.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2015 |
Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT.
Topics: Adult; Aged; Aged, 80 and over; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Female; Humans; Image Enhancement; Imaging, Three-Dimensional; Iohexol; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Observer Variation; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Preoperative Care; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
MR imaging features of small solid pseudopapillary tumors: retrospective differentiation from other small solid pancreatic tumors.
Topics: Adenocarcinoma; Carcinoma, Papillary; Contrast Media; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Neoplasms; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Statistics, Nonparametric | 2010 |
Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer.
Topics: Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Humans; Iopamidol; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Neoplasms; Prospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2011 |
Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Fibrosis; Humans; Image Interpretation, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neovascularization, Pathologic; Organometallic Compounds; Pancreatic Diseases; Pancreatic Neoplasms; Prospective Studies; ROC Curve; Statistics, Nonparametric; Tomography, X-Ray Computed | 2011 |
It is diamond cut diamond when CT meets MR imaging in the evaluation of pancreatic cancer.
Topics: Contrast Media; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pancreatic Neoplasms; Tomography, X-Ray Computed | 2011 |
An aqueous formulation of gamma-linolenic acid with anti-proliferative action on human pancreatic cancer cell lines.
Topics: Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; gamma-Linolenic Acid; Humans; Lithium Compounds; Meglumine; Pancreatic Neoplasms; Solutions; Time Factors; Tumor Cells, Cultured; Water | 2004 |
Small pancreatic adenocarcinomas: efficacy of MR imaging with fat suppression and gadolinium enhancement.
Topics: Adenocarcinoma; Aged; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Retrospective Studies; Tomography, X-Ray Computed | 1994 |
Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.
Topics: Adenoma, Islet Cell; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Prospective Studies; Retrospective Studies; Tomography, X-Ray Computed | 1993 |
3DFT-flash MR imaging of pancreatic cancer with gadopentetate dimeglumine.
Topics: Adult; Aged; Contrast Media; Drug Combinations; Female; Fourier Analysis; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Neoplasms; Pentetic Acid | 1996 |
Divergent proliferative responses to a gastrin receptor ligand in synchronized and unsynchronized rat pancreatic AR42J tumour cells.
Topics: Animals; Antineoplastic Agents; Cell Division; Gastrins; Hormone Antagonists; Indoles; Ligands; Meglumine; Pancreatic Neoplasms; Rats; Receptors, Cholecystokinin; Signal Transduction; Tumor Cells, Cultured | 2000 |
Dynamic gadolinium-enhanced MR imaging of pancreatic VIPoma in a patient with Verner-Morrison syndrome.
Topics: Aged; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pancreatic Neoplasms; Vipoma | 2001 |
Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression.
Topics: Adult; Aged; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pancreatic Diseases; Pancreatic Neoplasms; Pancreatitis; Pentetic Acid; Prospective Studies; ROC Curve; Tomography, X-Ray Computed | 1991 |